RA
PRAH

Ramius Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ramius Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,990
Closed -$305K – 480
2021
Q1 		$305K Buy
+1,990
New +$270K 0.08% 194

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Ramius Advisors's PRAH Position: Q2 2021 in Review

Ramius Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 1,990 shares — an estimated $305K sold.

Ramius Advisors first reported a position in PRAH in Q1 2021 and held it in 1 quarter. The position peaked at $305K in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Ramius Advisors reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ramius Advisors sold 1,990 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $305K.
  • Ramius Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 1 quarter.
  • Ramius Advisors's PRA Health Sciences, Inc. position peaked at $305K in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Ramius Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.